Google
MDCX 株価分析 — MEDICUS PHARMA LTD. COMMON STOCK (Healthcare >> Drug Manufacturers - General)
MDCX に関するよくある質問
MDCXのROE（自己資本利益率）は？
MEDICUS PHARMA LTD. COMMON STOCKのROEは-2,785.23%です。
MDCXの配当利回りは？
MEDICUS PHARMA LTD. COMMON STOCKの配当利回りは0.00%です。
MDCXの品質スコア（Quality Score）は？
当社のAIはMDCXの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
MDCXは今が買い時ですか？
当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
MDCXはどのセクターに属しますか？
MEDICUS PHARMA LTD. COMMON STOCKはHealthcare >> Drug Manufacturers - Generalセクターに分類されます（NASDAQ市場）
MDCX AI Analysis Summary
Our AI summary for MDCX: MEDICUS PHARMA LTD. COMMON STOCK (NASDAQ), Healthcare >> Drug Manufacturers - General sector. The stock currently trades at a P/E of 0.00, ROE of -2,785.23%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.28
Price
0.01
(4.80%)
Day Change
|
|
|---|
MDCX, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
ROEが昨年度比で低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.28 |
| PBV / Sector |
10.42 / 2.68
|
| Earning Per Share | -0.68 |
| PE / Sector |
N/A / 27.65
|
| PEG or PE/Growth / Sector |
N/A / 0.28
|
| Average 1M Daily Value |
0.49 M
GREAT
|
| Average 1W Daily Value |
0.68 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:09 |
| Symbol | MDCX |
| Name | MEDICUS PHARMA LTD. COMMON STOCK |
| Sector | Healthcare >> Drug Manufacturers - General |
| Market | NASDAQ |
| Listed Shares | 56.66 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 14.88 / 256,404.20 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 300 Conshohocken State Road, West Conshohocken, PA, United States, 19428
Phone: 610 636 0184
Website: https://medicuspharma.com
Description: Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
ME vs SECTOR Healthcare >> Drug Manufacturers - General
Click a bubble to view stock details · Bubble size represents market capitalization share
